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The characteristics of tuberculosis (TB) patients related to a chain of recent TB transmissions were investigated. 
Mycobacterium tuberculosis (MTB) isolates (120) were genotyped using the restriction fragment length polymor-
phism-IS6110 (R), spacer oligotyping (S) and mycobacterial interspersed repetitive units-variable number of tandem 
repeats (M) methods. The MTB isolates were clustered and the clusters were grouped according to the similarities 
of their genotypes. Spearman’s rank correlation coefficients between the groups of MTB isolates with similar geno-
types and those patient characteristics indicating a risk for a pulmonary TB (PTB) chain transmission were ana- 
lysed. The isolates showing similar genotypes were distributed as follows: SMR (5%), SM (12.5%), SR (1.67%), MR 
(0%), S (46.67%), M (5%) and R (0%). The remaining 35 cases were orphans. SMR exhibited a significant correlation 
(p < 0.05) with visits to clinics, municipalities and comorbidities (primarily diabetes mellitus). S correlated with drug 
consumption and M with comorbidities. SMR is needed to identify a social network in metropolitan areas for PTB 
transmission and S and M are able to detect risk factors as secondary components of a transmission chain of TB.
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The research methods for pulmonary tuberculosis 
(PTB) transmission have been refined in community-
based studies. Within a target population, patients in-
fected by isolates with identical DNA genotypes are 
assumed to be part of a PTB-transmission chain. Cluster-
ing is used as a proxy for recent transmission (Teeter et 
al. 2013). Population target-directed surveys performed 
to find TB micro-epidemics within specific groups of 
individuals have given excellent results in identifying 
household clusters (Verver et al. 2004, Park et al. 2008) 
or larger well-identified social networks (Quitugua et al. 
2002, Clark et al. 2006, Supply et al. 2006, Oelemann 
et al. 2007, Jimenez-Corona et al. 2009). In addition, 
universal genotyping is a valuable tool to identify un-
suspected recent PTB transmissions and previously 
unrecognised sites of transmission (Malakmadze et al. 
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2005). The above-mentioned surveys are frequently per-
formed in small communities and well-delimited zones 
and when PTB control in large cities requires the iden-
tification of the factors favouring a recent chain of PTB 
transmission, finding a common cause of PTB transmis-
sion is typically uncertain and very difficult (Pfyffer et 
al. 1998). Therefore, alternative approaches are required 
(Cook 2004). Before this study was conducted, we con-
sidered the following three facts: (i) if only one set of ge-
netic markers was chosen to perform a population-based 
study, only a fraction or no Mycobacterium tuberculosis 
(MTB) isolates with identical markers could be directly 
related to the major causative factor of a transmission 
chain of TB, improving the discriminatory power of the 
genotyping procedure is needed, (ii) selecting the factors 
primarily related to a transmission chain of TB is crucial 
and (iii) a reliable connection between the genotyping 
results and those factors most strongly connected to re-
cent events involved in TB transmission is required. Re-
garding the first issue, using a combination of two geno-
typing techniques to improve the discriminatory power 
of genotyping methods has been proposed. It has been 
noted that even two methods could not be sufficiently 
discriminative (Gori et al. 2005a). Other researchers 
have proposed using three combined genotyping meth-
ods to increase the probability of finding clusters of the 
characteristics of TB patients that are considered to be 
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possible facilitating factors of PTB transmission. These 
characteristics have been divided into social networks, 
specifically crowded places where people frequently re-
main a long time (Cook et al. 2007) and risk factors such 
as the consumption of drugs, comorbidities, resistance to 
anti-tubercular drugs (Davies 2005) and indoor air pollu-
tion (Narasimhan et al. 2013). The third prerequisite for 
our investigation was to select a good method of finding 
a strong relationship between the MTB genotypes and 
the PTB patient characteristics. Thus, we hypothesised 
that if a statistical correlation between groups of isolates 
showing similar genotypes and peril factors were found, 
identifying micro-epidemics and the causes of a recent 
PTB transmission chain could be possible. We selected 
three of the most recognised methods used in molecular 
epidemiological studies of TB. These methods were re-
striction fragment length polymorphism (RFLP)-IS6110 
(van Soolingen et al. 2001), spoligotyping (spacer oligo-
typing) (de la Salmonière et al. 1997) and mycobacterial 
interspersed repetitive units-variable number tandem re-
peats (MIRU-VNTR) (Cowan et al. 2002, Supply et al. 
2006). Each of these procedures employs a defined set of 
MTB genetic markers to perform epidemiological studies. 
The percentages of similitude obtained with the marker 
sets determined with spoligotyping, MIRU-VNTR and 
RFLP-IS6110 are reproducible and globally comparable 
(Frothingham & Meeker-O’Connell 1998, Cowan et al. 
2005, Gori et al. 2005b, Supply et al. 2006).
This survey was performed in Nuevo León, Mexico. 
The metropolitan area of Monterrey (MAM) is an indus-
trialised setting comprising nine municipalities (Apoda-
ca, García, San Pedro Garza García, General Escobedo, 
Guadalupe, Monterrey, San Nicolás de los Garza and 
Santa Catarina). The MAM has a population of 4.2 mil-
lion people (GENL 2014) and most of the population of 
Nuevo León (88%) is in the MAM (GENL 2014). In 2012, 
15,858 new cases of PTB were diagnosed in Mexico [rate 
(cases/100,000 inhabitants) = 17.4]. Nuevo León reported 
an incidence rate that was 33.6% higher than the national 
rate (1,074 new cases; rate = 30.8) (SS/México 2012).
In this study, we investigated the following inquiries: 
(i) how are MTB isolates organised into clusters and 
groups of clusters by applying the three aforementioned 
genotyping methods?, (ii) which clusters or groups of 
clusters were most strongly related to social networks or 
risk factors? and (iii) which PTB patient characteristics 
could cause the recent PTB transmission?
PATIENTS, MATERIALS AND METHODS
Target population - The target population consisted 
of 120 TB patients living in the MAM who were ensured 
by the Mexican Institute of Social Security (IMSS 2014). 
The IMSS provides health care for 83.5% of the patients 
in Nuevo León. During a 16-month period, all patients 
who visited the units of familiar medicine of the MAM 
with symptoms suggestive of PTB [268 (100% of the 
suspicious cases in the MAM in the care of the IMSS)] 
were included in this study. A total of 134 patients had 
MTB-positive sputum samples and 120 of these patients 
agreed to participate in this study. The study group was 
composed of 64% men and 36% women between the ages 
of 13-84 years (median = 49 years). The range of ages 
was 18-68 years and the time of residence in the MAM 
ranged from less than one year to 68 years (mean ± stan-
dard deviation = 34.06 ± 16.03 years). The participants 
presented clear symptoms of PTB (WHO 2014) and acid-
fast bacilli (AFB) in their sputum samples. PTB patients 
attended their respective family medicine clinics or their 
zone hospitals during the study. In these facilities, the pa-
tients were diagnosed by a pulmonologist or epidemiolo-
gist. AFB were detected and reported by a chemist work-
ing in the clinical laboratory of each medical facility.
Collection of data regarding potential TB risk fac-
tors - The collection of epidemiological data and the iso-
lation, MTB typing and genotyping were performed in 
the Northeast Biomedical Research Centre (CIBIN) of 
the IMSS. The patients with a clinical diagnosis of PTB 
signed an informed consent form and answered a ques-
tionnaire to provide appropriate information regarding 
the factors that could favour TB transmission (such as 
crowded places frequented by the PTB patients). Fa-
milial contacts and human immunodeficiency virus/ac-
quired immune deficiency syndrome status were sought 
and correlated with the clusters; additionally, groups of 
clusters were analysed, but because the data were nega-
tive, these results are not presented in this article.
Social networks and risk factors - The elements of so-
cial networks analysed in this work were family medical 
clinics, zonal general hospitals, municipalities and familial 
contacts. The risk factors examined were comorbidities, 
patterns of resistance or sensitivity to first line anti-tuber-
cular drugs, occupation and drug consumption (alcohol-
ism, tobacco use and psychotropic substance abuse).
Control MTB strain - The MTB H37Rv strain 
(American Type Culture Collection, catalogue 27294) 
was included as an internal genotyping control.
MTB isolates - Each participant donated up to three 
sputum samples from which mycobacteria were isolated 
and typified. Immediately after collection, the samples 
were transported to our laboratory in the CIBIN, de-
contaminated and the bacteria were concentrated by 
centrifugation. A smear from every sputum sample was 
prepared and stained using the Ziehl-Neelsen method 
and AFB were microscopically examined (Ellis & Za-
browarny 1993). Each of these samples was inoculated 
onto Lowenstein-Jensen (LJ) slants (Becton Dickinson, 
USA) and incubated in a 5% CO2 atmosphere at 37ºC for 
two-five weeks. Slants with typical MTB colonies were 
typified (Kent & Kubica 1985, Balandrano-Campos et 
al. 1996) and stored at -70ºC until use. One MTB isolate 
per patient was included in this study.
Recovery of frozen isolates - The frozen MTB iso-
lates were thawed at -20ºC overnight and then at 4ºC for 
3-4 h. Mycobacteria were inoculated on LJ slants and 
incubated at 37ºC until colonies were clearly visible.
Drug sensitivity tests for first-line anti-MTB drugs 
- The tests were performed with a Bactec 460 radio-
metric system (Siddiqi 1996). The assayed drugs were 
isoniazid (INH) (0.1 g/mL), streptomycin (2.0 g/mL), 
816 Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 109(6), September 2014
rifampicin (RIF) (2.0 g/mL), ethambutol (2.5 g/mL) 
and pyrazinamide (100 mg/mL). All anti-TB drugs 
were purchased from Becton Dickinson.
Extraction of MTB DNA - Under aseptic conditions, 
two loops of mycobacteria colonies were transferred to 
a glass test tube containing 2.5 mL of Tris-EDTA buffer 
[10 mM Tris/HCl pH 8) (Amresco, USA) and 1.0 mM 
EDTA (Promega, USA)] and five-six glass beads. The 
suspension was homogenised using a vortex and a 0.5-
mL aliquot was transferred to a 1.5-mL capped conical 
polypropylene tube (Eppendorf, Germany) and inacti-
vated in an 80ºC water bath (Terlab M40, Mexico) for 50 
min. DNA was extracted from mycobacteria according 
to the CTAB (hexadecyltrimethyl-ammonium bromide) 
method (van Soolingen et al. 2001).
Genotyping procedures - MTB spoligotypes were 
analysed according to Kamerbeek et al. (1997) using a 
commercial kit (Isogen Life Science, the Netherlands). 
RFLP-IS6110 analyses were performed according to van 
Embden et al. (1993) and MIRU-VNTR analyses were 
performed according to Cowan et al. (2002) and Sup-
ply et al. (2006). To identify the MIRU and VNTR, the 
following 15 loci were analysed: MIRU 4, 10, 16, 26, 
31 and 40 (Cowan et al. 2002) as well as Mtub 04, ETR 
C, ETR A, QUB 11b, Mtub21, QUB26, Mtub30, Mtub39 
and QUB4156 (Supply et al. 2006).
Analysis of genotyping data - Based on the findings 
of Lindquist et al. (2013), we defined clusters as those 
PTB cases with indistinguishable MTB genotypes. The 
spoligotypes were converted to their corresponding oc-
tal codes as described by Dale et al. (2001) and clusters 
and unique patterns were identified using SPSS soft-
ware, v.10.0. The RFLP-IS6110 data were analysed with 
BioNumerics software, v.2.0 (Applied Maths, Belgium) 
using the unweighted pair group method with an arith-
metical mean and Dice’s coefficient. The running dif-
ferences in the gels were normalised using the relative 
position of the λ/Hind III and φX174/Hae III molecu-
lar weight markers (Sigma-Aldrich) using BioNumer-
ics software. To determine the best tolerance, a DNA 
sample from the reference strain H37Rv was included 
in each assay. When the alignments of all of the refer-
ence RFLP-IS6110 patterns from all the agarose gels 
matched, the tolerance value was set at 1.9%. The geno-
types were considered identical according to the results 
from the analyses performed by the BioNumerics pro-
gram. Because RFLP-IS6110 codes have not been previ-
ously described, we designed a code using the relative 
migration of each IS6110 band (Rf) of every MTB iso-
late DNA sample (Fig. 1). The description of the RFLP-
IS6110 codes is as follows: the RFLP-IS6110 codes have 
two arms of numbers, separated by a dot. The left arm 
is composed of one or two digits and includes informa-
tion regarding the number of bands found in each MTB 
isolate. The right arm contains the Rf of each DNA band 
with an IS-6110 element. Each Rf is represented by three 
numbers. From left to right, the Rf values were placed 
in descending order of DNA-molecular weight. The Rf 
values were calculated by dividing the distance between 
Fig. 1: restriction fragment length polymorphism (RFLP)-IS6110 
diagram and dendrogram. These were generated by the BioNumerics 
software and show the relationships of clusters and groups of clusters 
using the RFLP-IS6110 method exclusively. Numbers on the right 
side are case-identifiers.
MTB genotype related to risk factors • Katia Peñuelas-Urquides et al. 817
the origin and front of the electrophoresis by the distance 
travelled by each IS6110-band and multiplying by 1 × 103. 
The MIRU-VNTR patterns were analysed with Microsoft 
Excel 2002 software (Microsoft Co, USA). The corre-
sponding codes were constructed according to Cowan et 
al. (2002) and Supply et al. (2006). The cluster groups with 
comparable codes were named as follows to differentiate 
the clusters from the genotyping methods: spoligotypes, 
MIRU-VNTR and RFLP-IS6110, SMR, spoligotypes and 
RFLP-IS6110, SR, spoligotypes and MIRU-VNTR, SM, 
MIRU-VNTR and RFLP-IS6110, MR, spoligotypes, S, 
RFLP-IS6110, R, and MIRU-VNTR, M. The methods are 
referred to by their corresponding shortened names (spo-
ligotyping, MIRU-VNTR and RFLP-IS6110).
Venn diagram - The Venn diagram describes the met-
rics by which the 120 MTB isolates were organised using 
spoligotyping, MIRU-VNTR and RFLP-IS6110. The dia-
gram was constructed using PowerPoint software for Win-
dows 7 (Microsoft Co) with the data depicted in Table I.
Statistics - The significance (p = 0.05) for correla-
tion between the aforementioned cluster-groups and the 
PTB characteristics was calculated by Spearman’s σ. 
Statistical correlation referred to the relationships that 
involved the dependence of code-set belonging to each 
MTB cluster group having comparable genetic codes 
and each PTB patient characteristic.
Ethics - This protocol represented a minor risk 
for TB patients and was authorised by the Scientif-
ic and Ethical Committee of the CIBIN/IMSS (pro-
tocol R-2005-1908-2).
RESULTS
Genotyping - RFLP-IS6110 patterns - Fig. 1 shows the 
RFLP-IS6110 patterns and dendrogram of the 120 PTB 
clinical isolates. The Venn diagram (Fig. 2) describes the 
metrics by which the 120 MTB isolates were organised 
using spoligotyping, MIRU-VNTR and RFLP-IS6110. 
While 70.83% (85) of the isolates were clustered, 29.17% 
(35) of the isolates (unique or orphan cases) were not 
clustered by any genotyping method. The clusters consti-
tuted the following groups with respect to the 120 MTB 
isolates: SMR, 5% (6 isolates), SM, 12.50% (15 isolates), 
SR, 1.60% (2 isolates), M, 5% (6 isolates) and S, 46.67% 
(56 isolates). MR and R clusters were not observed. 
Supplementary data, Table I shows each case identified 
by the number assigned by our laboratory and its cor-
responding S, M or R code. Supplementary data, Table 
II retains the identical organisation of the MTB cases as 
clusters and groups of clusters, as in Supplementary data, 
Table I. Supplementary data, Table II depicts the factors 
that could favour PTB transmission in our target popula-
tion. Five groups were formed with comparable codes for 
spoligotyping, MIRU-VNTR and RFLP-IS6110 (SMR), a 
combination of two codes (SR and SM) or only one (S and 
M). Group six was formed by orphan cases. Additional-
ly, Supplementary data, Table II shows that the variables 
with the highest frequencies were first (family medicine 
clinic 35) and second level medical facilities (zonal gen-
eral hospitals 4 and 17), municipalities (Guadalupe and 
Monterrey), comorbidities (diabetes mellitus type 2), oc-
cupation (car painting, mining and industrial production), 
multidrug resistance (to at least RIF and INH) and drug 
consumption (tobacco use and alcoholism).
Association of cluster groups with situations favour-
ing TB transmission - Tables I, II show the association of 
cluster groups with crowded places frequented by PTB 
patients and risk factors. SMR presented a significant 
correlation with family medicine clinics, municipalities, 
comorbidities and drug consumption. SR and factors fa-
vouring MTB transmission were not calculated because 
the number of cases was insufficient. M exhibited cor-
relation with comorbidity. No relationship was found be-
tween a cluster group and members of the same family 
or neighbours.
DISCUSSION
We showed that a combination of RFLP-IS6110, 
MIRU-VNTR and spoligotyping is essential to identify 
MTB clusters, to group the clusters and to discard orphan 
cases. Using these data, we investigated how social net-
works and risk factors correlated with the cluster groups 
(Glynn et al. 2002, Hasan et al. 2006, Narasimhan et al. 
2013). SMR was the only group that correlated with two 
of the three elements of social networks and with two of 
the four risk factors considered in this study. Our data 
strongly suggest that when TB surveys are performed in 
a metropolis, such as the MAM, the more markers that 
are considered in performing a correlation analysis with 
risk factors, the more reliable the connection with a PTB 
epidemic focus would be.
The factors that correlated with SMR substantiated 
a recent MTB transmission. Regarding social networks 
(family medicine clinics, primary clinics and municipal-
ities), patients typically remain a long time in crowded 
waiting rooms. Clinic waiting rooms are closed envi-
ronments with recirculated air, in which bacillipherous 
patients are seated by individuals without PTB. During 
TABLE I
Association of cluster-groups and social networks
Groupa
Level of medical attention
Municipality
Clinics of 
familiar medicine
Zonal 
general hospitals
Spearman’s correlation
SMR 0.033 0.166 0.013
SR NCb NC NC
SM 0.677 0.256 0.380
S 0.078 0.105 0.316
M 0.779 0.559 0.261
a: groups of clusters having comparable codes; b: not computa-
ble (NC) because these groups were constituted just by one clus-
ter having two cases. Capitals correspond to groups of clusters 
showing comparable codes of spoligotyping (S), mycobacterial 
interspersed repetitive units-variable number tandem repeats 
(M) or restriction fragment length polymorphism-IS6110 (R). 
Bold numbers indicate statistical significance (p ≤ 0.05).
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standard treatment, patients repeat this type of visit sev-
eral times. No correlation was observed between SMR 
and zonal general hospitals, possibly because TB pa-
tients are treated in family medicine clinics by an epide-
miologist until the case of TB is cured or the patient is 
referred to a pulmonologist at a specialty hospital. Thus, 
the risk of PTB transmission in second level facilities is 
markedly reduced. PTB transmission throughout social 
networks has been previously reported; García-García et 
al. (2000) found an RFLP-IS6110 cluster that developed 
after PTB micro-epidemics occurred in a social network 
formed by assiduous clients attending clandestine bars. 
In addition to first level medical facilities, workers and 
housewives typically frequent the same crowded pub-
lic places, such as schools, markets, stores, cinemas, 
churches or bars and are transported by urban buses. 
A significant proportion of our patients had diabetes or 
abused drugs. These factors are recognised as risk fac-
tors (Davies 2005) and we identified the correlations of 
diabetes and drug abuse with SMR.
The application of a combination of spoligotyp-
ing, MIRU-VNTR and RFLP-IS6110 and an analysis 
of Spearman’s correlation of these genotypes with fac-
tors that could facilitate MTB transmission is required 
to discover new PTB micro-epidemics that are possible 
in a metropolitan population. Considering the increase 
in multidrug resistant and extended drug resistant MTB 
strains that threaten TB control worldwide (WHO 2014), 
the recent development of strains resistant to all first and 
second line anti-TB drugs, which have been identified as 
completely MTB resistant (totally drug-resistant-MTB) 
(Rowland 2012), could be useful for applying analyses 
such as this one to describe future TB surveys or poten-
tial epidemic foci of PTB.
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